Qube Research & Technologies (QRT)
CGTX icon

Qube Research & Technologies (QRT)’s Cognition Therapeutics CGTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,078
Closed -$23.1K – 3587
2025
Q4 		$23.1K Buy
+17,078
New +$27.7K ﹤0.01% 3370
2024
Q2 		– Sell
-2,121
Closed -$3.86K – 3891
2024
Q1 		$3.86K Buy
+2,121
New +$4.38K ﹤0.01% 3922

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CGTX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Cognition Therapeutics (CGTX) in Q1 2026, closing a stake of 17,078 shares — an estimated $23.1K sold.

Qube Research & Technologies (QRT) first reported a position in CGTX in Q1 2024 and held it in 2 quarters. The position peaked at $23.1K in Q4 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Cognition Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 17,078 Cognition Therapeutics shares in Q1 2026, an estimated $23.1K.
  • Qube Research & Technologies (QRT) first reported a position in Cognition Therapeutics in Q1 2024 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Cognition Therapeutics position peaked at $23.1K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.